## About Dataset

This dataset comprises comprehensive health information for patients who underwent examination to get diagnosed with Parkinson's Disease, each uniquely identified with IDs ranging from 3058 to 5162. The dataset includes demographic details, lifestyle factors, medical history, clinical measurements, cognitive and functional assessments, and symptoms.

## Table of Contents

1. **Patient Information**
   - Patient ID
   - Demographic Details
   - Lifestyle Factors
2. **Medical History**
3. **Clinical Measurements**
4. **Cognitive and Functional Assessments**
5. **Symptoms**
6. **Confidential Information**

## Patient Information

### Patient ID

- **PatientID**: A unique identifier assigned to each patient (3058 to 5162).

### Demographic Details

- **Age**: The age of the patients ranges from 50 to 90 years.
- **Gender**: Gender of the patients.
- **Ethnicity**: The ethnicity of the patients.
- **EducationLevel**: The education level of the patients.

### Lifestyle Factors

- **BMI**: Body Mass Index of the patients.
- **Smoking**: Smoking status.
- **AlcoholConsumption**: Weekly alcohol consumption in units.
- **PhysicalActivity**: Weekly physical activity in hours.
- **DietQuality**: Diet quality score.
- **SleepQuality**: Sleep quality score.

## Medical History

- **FamilyHistoryParkinsons**: Family history of Parkinson's Disease.
- **TraumaticBrainInjury**: History of traumatic brain injury.
- **Hypertension**: Presence of hypertension.
- **Diabetes**: Presence of diabetes.
- **Depression**: Presence of depression.
- **Stroke**: History of stroke.

## Clinical Measurements

- **SystolicBP**: Systolic blood pressure, ranging from 90 to 180 mmHg.
- **DiastolicBP**: Diastolic blood pressure, ranging from 60 to 120 mmHg.
- **CholesterolTotal**: Total cholesterol levels, ranging from 150 to 300 mg/dL.
- **CholesterolLDL**: Low-density lipoprotein cholesterol levels, ranging from 50 to 200 mg/dL.
- **CholesterolHDL**: High-density lipoprotein cholesterol levels, ranging from 20 to 100 mg/dL.
- **CholesterolTriglycerides**: Triglycerides levels, ranging from 50 to 400 mg/dL.

## Cognitive and Functional Assessments

- **UPDRS (target variable)** : Unified Parkinson's Disease Rating Scale score, ranging from 0 to 199. Higher scores indicate greater severity of the disease.
- **MoCA**: Montreal Cognitive Assessment score, ranging from 0 to 30. Lower scores indicate cognitive impairment.
- **FunctionalAssessment**: Functional assessment score, ranging from 0 to 10. Lower scores indicate greater impairment.

## Symptoms

- **Tremor**: Presence of tremor.
- **Rigidity**: Presence of muscle rigidity.
- **Bradykinesia**: Presence of bradykinesia (slowness of movement).
- **PosturalInstability**: Presence of postural instability.
- **SpeechProblems**: Presence of speech problems.
- **SleepDisorders**: Presence of sleep disorders.
- **Constipation**: Presence of constipation.

## Confidential Information

- **DoctorInCharge**: This column contains confidential information about the doctor in charge, with "DrXXXConfid" as the value for all patients.

## Conclusion

This dataset offers extensive insights into the factors associated with Parkinson's Disease, including demographic, lifestyle, medical, cognitive, and functional variables. It is ideal for developing predictive models, conducting statistical analyses, and exploring the complex interplay of factors contributing to Parkinson's Disease.
